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Background: Most primary headaches are episodic, and most estimates of the heavy disability burden attributed to
headache derive from epidemiological data focused on the episodic subtypes of migraine and tension-type
headache (TTH). These disorders give rise directly but intermittently to symptom burden. Nevertheless, people with
these disorders may not be symptom-free between attacks. We analysed the Eurolight dataset for interictal burden.
Methods: Eurolight was a cross-sectional survey using modified cluster sampling from the adult population
(18–65 years) in 10 countries of the European Union. We used data from nine. The questionnaire included
headache-diagnostic questions based on ICHD-II and several question sets addressing impact, including
interictal and cumulative burdens.
Results: There were 6455 participants with headache (male 2444 [37.9 %]). Interictal symptoms were reported
by 26.0 % of those with migraine and 18.9 % with TTH: interictal anxiety by 10.6 % with migraine and avoidance
(lifestyle compromise) by 14.8 %, both much more common than in TTH (3.1 % [OR 3.8] and 4.7 % [OR 3.5]
respectively). Mean time spent in the interictal state was 317 days/year for migraine, 331 days/year for TTH. Those who
were “rarely” or “never” in control of their headaches (migraine 15.2 %, TTH 9.6 %) had significantly raised odds of
interictal anxiety, avoidance and other interictal symptoms. Among those with migraine, interictal anxiety increased
markedly with headache intensity and frequency, avoidance less so but still significantly. Lost productive time was
associated with high ORs (up to 5.3) of anxiety and avoidance.
A third (32.9 %) with migraine and a quarter (26.7 %) with TTH (difference: p < 0.0001) were reluctant to tell others of
their headaches. About 10 % with each disorder felt families and friends did not understand their headaches. Nearly
12 % with migraine reported their employers and colleagues did not.
Regarding cumulative burden, 11.8 % reported they had done less well in education because of headache, 5.9 %
reported reduced earnings and 7.4 % that their careers had suffered.
Conclusions: Interictal burden in those with episodic headache is common, more so in migraine than TTH. Some
elements have the potential to be profoundly consequential. New methodology is needed to measure interictal
burden if descriptions of headache burden are to be complete.
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Headache disorders, especially tension-type headache
(TTH) and migraine, are extremely common [1]. From a
public-health perspective, and also from the viewpoint of
affected people, they are also among the most disabling:
migraine is the sixth highest cause in the world of years
of healthy life lost to disability (YLDs), and headache
disorders collectively are third, according to the Global
Burden of Disease Study 2013 (GBD2013) [2, 3]. Various
causes of headache occurring on ≥15 days every month
affect 2–4 % of the world’s adult population [4]. Among
these, medication-overuse headache (MOH) affects 1–2 %
[5], and this disorder is itself among the top 20 causes
(18th) of YLDs [2, 3]. Nevertheless, most primary head-
aches are episodic, and most of the disability burden
attributed to headache in GBD2013 was based on epi-
demiological data focused on the episodic subtypes of
migraine and TTH. These disorders give rise directly,
but intermittently, to symptom burden: pain, often ac-
companied in the case of migraine by nausea, vomiting
and photo- and/or phonophobia. All of these tend to
cause debility, prostration and reduced functional abil-
ity, a secondary disability burden which is the principal
cause of YLDs and consequential lost productivity.
This ictal burden is easily conceptualised; but it has
long been recognised that people with episodic headache
may not be entirely symptom-free between attacks [6, 7].
There are good reasons for this. Since headache attacks
are unpleasant, people who experience them wish not to
do so. Those in whom they occur frequently are very
likely to worry about when the next may happen, and in
some this can reach a level of anxiety. More commonly
it may provoke avoidance behaviour, particularly among
those with migraine who identify triggers and endeavour
to eliminate them by lifestyle compromise. Sensible this
may be, but too much lifestyle compromise may take the
pleasure out of life. An example given by Stovner et al.
was this: “Leisure activities may be cancelled or curtailed
because of headache; when many have been cancelled,
social events are likely not to be planned in the first
place. Social life between attacks may simply cease” [7].
These are elements of interictal burden.
The health and wellbeing importance of interictal bur-
den lies in its continuity. Whereas the ictal burden of
episodic headache is typically present during only one or
two days in every month, interictal burden can impose
itself on all of the other days. This means two things.
First, interictal burden ought not to be ignored: the bur-
den of headache is very poorly described if it does not
take interictal burden into account. Second, if interictal
burden is overestimated, then multiplied by time, quan-
tification of overall burden is likely to be greatly dis-
torted. GBD2010 described distinct ictal and interictal
health states associated with both migraine and TTH,and allocated disability weights (DWs) to each, but the
interictal DWs and burden estimates arising from them
were not reported [1], probably for this reason.
In fact there is little empirical knowledge about inter-
ictal burden. Furthermore, while it has been described
[6–10], it has no accepted definition. A single Swedish
study has made a population-based estimate of preva-
lence [11], but this described only the proportion of
people with migraine (43 %) who recovered completely
between attacks. There are no published studies that
have estimated magnitude. We may assume that signifi-
cant relationships exist between interictal burden and
the behaviour, performance, productivity, family life and
social activities of those affected, but no data exist to
confirm these.
The Eurolight project, supported by the European
Commission Public Health Executive Agency, was a
partnership activity within the Global Campaign against
Headache. Its main purpose was to gather knowledge of
the impact of headache disorders of public-health im-
portance across Europe. Its questionnaire included a
number of question sets designed to capture elements of
headache-attributed burden, among which were those
likely to be experienced interictally. We analysed the
Eurolight dataset accordingly, and report our findings
here. Our working definition of interictal burden was:
“Any loss of health or wellbeing attributable to a head-
ache disorder reportedly experienced while headache-
free.” It has multiple components [10]; those addressed
by the Eurolight questionnaire included interictal anx-
iety, avoidance behaviour and non-headache symptoms;
perceptions of poor headache control, stigma and social
isolation; and the cumulative burdens engendered by
disturbed education, lost career opportunities and dam-
aged family life.
Methods
The original Eurolight survey was conducted from No-
vember 2008 to August 2009. The full methodology is
described elsewhere [12]; below we present brief details.
The survey was of cross-sectional design and used modified
cluster sampling in 10 countries (Austria, France, Germany,
Ireland, Italy, Lithuania, Luxembourg, Netherlands, Spain
and United Kingdom) representing >60 % of the adult
population (18–65 years) of the European Union. The sam-
pling methods, summarised in Table 1, varied between
countries according to what was feasible [12]. Additional
samples in Spain and Netherlands, and the only sample in
Ireland, were recruited through patients’ organisations
[12]. To avoid the inevitable biases inherent in these, they
were not included in this analysis.
In all countries, the survey used the same structured
questionnaire [13], a derivative of the HARDSHIP ques-
tionnaire [10], translated into the local languages following
Table 1 Summary of data collection methods in each country
Country Sample size (n) Methods
Denominator Responders Responders
with headache
Austria up to 6000 646 454 Up to 10 consecutive patients aged 18–65 y visiting any of 400 general practitioners
(GPs) and 200 neurologists for any reason on a pre-specified day. Questionnaires to be
completed and returned later. One reminder after one month to non-responders.
France 2400 876 586 Consecutive patients aged 18–65 y attending any of a cooperative of 80 GPs on a
pre-specified day. Questionnaires to be completed and returned immediately or later
by post. One reminder by email after one week to non-responders.
Germany 3000 338 248 Random urban (50 %) and rural (50 %) samples aged 18–65 y from general population
listings supplied by local municipal authority. Questionnaires distributed and returned by
post. No reminders sent.
Italy 3500 500 374 Random urban (70 %) and rural (30 %) samples drawn from general population using
listings supplied by Azienda Sanitaria Locale of Pavia, stratified with regard to gender,
age (in range 18–65 y) and education. Questionnaires distributed and returned by post.
No reminders sent.
Lithuania 1137 616 440 Sample drawn from Kaunas city and Kaunas region using Residents’ Register Service,
reflecting age (in range 18–65 y) and gender composition of Lithuania and proportions
living in rural (33 %) or urban (67 %) areas. Data collection face-to-face, conducted by
medical students “cold-calling” door-to-door.
Luxembourg 6498 2023 1473 Sample aged 18–65 y, stratified for age, gender, region and nationality, drawn from
general population via national social security registry (IGSS). Questionnaires distributed
and returned by post. Reminders sent one month later to non-responders.
Netherlands unknown 2414 1993 Survey conducted by market research company with access to population sample of
200,000, representative with regard to gender, age (in range 18–65 y), region and
education. Questionnaire distributed by internet, to be completed on-line. Study
stopped when >2000 received back.
Spain 1700 999 797 Random sample of employees of companies operating in national postal services in 10
areas of Spain, stratified to be representative of general working population with regard
to gender, age (in range 18–65 y) and education. Ten occupational health physicians
delivered and took return of questionnaires. One telephone reminder to non-responders.
United
Kingdom
720 128 90 Modified population-based sampling through 12 GP practices in 11 areas (in UK, virtually
all residents are registered with local GP). Questionnaire given to consecutive patients
aged 18–65 y attending for any reason over a period of time, to be completed and
returned immediately, or later by post.
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ments [14]. Demographic questions were followed by
screening questions for headache and, in those screening
positively, by headache-diagnostic questions based on
ICHD-II [15]. Participants with more than one headache
type were asked to report only on the one they considered
most bothersome. Diagnoses were made by computerized
algorithm [10]. This first identified, and separated, partici-
pants reporting headache on ≥15 days/month (of whom
additional questions enquired into medication use), then
to the remainder applied ICHD-II criteria for migraine,
TTH, probable migraine and probable TTH in that order.
Thus a diagnosis of TTH trumped probable migraine [15].
In the analyses, migraine and probable migraine were con-
sidered together, as were TTH and probable TTH [7, 16].
Probable MOH (pMOH) was assumed to be the diagnosis
when headache frequency was ≥15 days/month, duration
was >4 h, the question “Do you usually take medication to
treat your headaches” was answered “yes”, and frequency
of acute medication use was ≥15 days/month when the
medication was simple analgesics only or ≥10 days/monthwhen it was any other (compound analgesics, opioids,
triptans and/or ergots). A diagnosis of pMOH trumped all
other diagnoses.
The questionnaire included several question sets ad-
dressing impact, including interictal and cumulative bur-
dens (Table 2). In addition, it imported, as modules, the
Headache-Attributed Lost Time (HALT) Index [17],
which enabled correlations of interictal with ictal bur-
den, and the Hospital Anxiety and Depression Scale
(HADS) [18].
Statistical analysis
Analyses were performed at the Norwegian University of
Science and Technology using SPSS version 21 and
Microsoft Excel version 14.0.7153.5000. In most cases
these were of participants’ responses to the various ques-
tions, summarised for all those with headache or by
diagnosis (migraine, TTH or pMOH). We described cat-
egorical variables as proportions (n [%]) and continuous
variables in terms of means and standard deviations
(SDs). We assumed interictal burden was present on
Table 2 Questions on interictal and cumulative burdens attributable to headache
Domain of enquiry Question Response options
(optimum response first)
Symptoms in the interictal period
(questions specifically about the last day when
the respondent did not have a headache)
On that day, were you anxious or worried about your next headache
episode?
no; yes
On that day, was there anything you could not do or did not do
because you wanted to avoid getting a headache?
no; yes
On that day, did you feel completely free from all headache-related
symptoms?
yes; no
Control of headaches Taking into account everything you do to treat your headaches, do you
feel you are in control of your headaches?
always; often; sometimes;
rarely; never
Stigma and social isolation Do you avoid telling people that you have headaches? no; yes
Do you feel that your family and friends understand and accept your
headaches?
yes; no
Do you feel that your employer and work colleagues understand and
accept your headaches?
yes; no
Cumulative burdens Have your headaches interfered with your education? no;
(multiple response options possible) yes, I did less well;
yes, I gave up early
Do you believe your headaches have made you less successful in your
career?
no;
(multiple response options possible) yes, I have done less well;
yes, I have taken an easier
job;
yes, I have taken long-
term sick leave;
yes, I have retired early;
yes, I am on a disability
pension
Have your headaches affected your family planning? no;
yes, I have had fewer
children;
yes, I have avoided having
children
During the last 3 months, have your headaches caused difficulties in
your love life?
no; yes
Have your headaches caused a relationship to break down? no;
yes, they have caused
separation;
yes, they have caused
divorce
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spent in interictal state (in days/year) as [365 – (reported
headache frequency in days/year)]. We reported this
variable in terms of means and standard errors (SEs).
We calculated odds ratio (ORs) and 95 % confidence
intervals (CIs) to show associations in bivariate ana-
lyses. We used chi-squared and Fisher’s exact tests of
significance.
Ethics
The National Ethics Committee of Luxembourg gave
overall approval of the protocol. Further approvals wereobtained from national or local ethics committees wher-
ever needed. Similarly, data protection approvals were
obtained centrally in Luxembourg and at country levels
in compliance with national and European laws.
In each country, prospective participants received a
written information sheet explaining the project and en-
quiry, and their purpose.
Results
Demographics and diagnoses
In total there were 6455 participants with any headache
from the nine countries (male 2444 [37.9 %], mean age
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40.8 ± 12.1 years). Among these, 2959 were diagnosed
with migraine, 3033 with TTH and 249 with pMOH
(Table 3).
Interictal anxiety, avoidance and other interictal
symptoms
Table 3 shows the proportions responding adversely to
each of the three questions (see Table 2), for all partici-
pants with headache and by diagnosis and gender. It also
shows, by diagnosis, the time in days/year spent with
interictal burden. With regard to the episodic headaches,
about one quarter (26.0 %) of participants with migraine
and just under one fifth (18.9 %) with TTH reported
interictal symptoms, in each case rather more males
than females. Interictal anxiety was reported by about
10 % of those with migraine, avoidance by about 15 %.
Both were much more common in migraine than TTH
(for interictal anxiety, OR 3.8 [95 % CI: 3.0–4.8]; for
avoidance, OR 3.5 [95 % CI: 2.9–4.3]). All proportions
were substantially higher in pMOH: we report them in
Table 3 for comparative interest, but note that, in any
headache occurring on ≥15 days/month, it is not easy to
discern what is ictal and what is interictal. For this rea-
son, we present no further analyses of pMOH.
About half (53.1 %) of those with migraine, and nearly
three quarters (71.4 %) with TTH, were “always” or
“often” in control of their headaches; on the other hand,
15.2 % with migraine and 9.6 % with TTH were “rarely”
or “never” so (Table 4). Gender differences were notable
in the proportions “always” in control, significantly
favouring males: for migraine, chi-squared = 43.923,
p < 0.0001; for TTH, chi-squared = 4.677, p = 0.0306.Table 3 Proportions of participants with headache reporting interict
Headache type Gender N Interictal anxiety
n (%) [95 % CI]
All Female 4011 344 (8.6) [7.7–9.5]
Male 2444 157 (6.4) [5.4–7.4]
All 6455 501 (7.8) [7.1–8.5]
Migraine Female 2042 224 (11.0) [9.6–12.4]
Male 917 91 (9.9) [8.0–11.8]
All 2959 315 (10.6) [9.5–11.7]
Tension–type headache Female 1657 51 (3.1) [2.3–3.9]
Male 1376 42 (3.1) [2.2–4.0]
All 3033 93 (3.1) [2.5–3.7]
Probable medication–overuse
headache
Female 188 53 (28.2) [21.8–34.6
Male 61 19 (31.1) [19.5–42.7
All 249 72 (28.9) [23.3–34.5We enquired into whether the probability of reporting
interictal burden would increase with greater reported
ictal burden (Table 5), although we did this only among
those with migraine because ictal burden generally re-
mains low in TTH. Interictal anxiety increased markedly
with headache intensity and frequency, avoidance less so
but still significantly. This was not the case with interic-
tal symptoms, where increased odds of reporting were
significant only among those with very high attack fre-
quencies (>90 days/year). Those reporting poor control
of their headaches had significantly raised odds of inter-
ictal anxiety, avoidance and other interictal symptoms.
Lost productive time measured by the HALT index, es-
pecially lost work time, was associated with quite high
odds (OR up to 5.3) of reporting interictal anxiety and
avoidance, although, with increasing lost work time be-
yond the range 12–22 days/3 months, these odds tended
to decline. With lost household work, the opposite was
the case (Table 5).
We wondered whether our enquiry into interictal anx-
iety might be influenced by general anxiety. We could
test this, because our enquiry included HADS; this en-
abled us to compare, for prevalence of interictal anxiety,
those with HADS-A scores in the normal range (<8),
borderline cases (scoring 8–10) and those at or above
the threshold score (11) for anxiety caseness [18]. We
performed this analysis in those with migraine, in whom
we found a clear gradient: 7.9 %, 10.4 % (OR 1.3 [95 %
CI: 1.0–1.8]; p = 0.072) and 17.8 % (OR 2.3 [95 % CI:
1.7–3.0]; p < 0.0001) respectively. We also repeated the
analysis shown in Table 3 after excluding participants
with HADS-A scores ≥11 (n = 1166). All proportions
with interictal symptoms were reduced, but most not byal burden, by headache type and gender
Interictal avoidance Not free of all
symptoms
Mean time in
interictal state
n (%) [95 % CI] n (%) [95 % CI] days/year
(mean ± SE)
441 (11.0) [10.0–12.0] 902 (22.5) [21.2–23.8] 316 ± 1
227 (9.3) [8.1–10.5] 575 (23.5) [21.8–25.2]
668 (10.3) [9.6–11.0] 1478 (22.9) [21.9–23.9]
302 (14.8) [13.3–16.3] 522 (25.6) [23.7–27.5] 317 ± 1
135 (14.7) [12.4–17.0] 248 (27.0) [24.1–29.9]
437 (14.8) [13.5–16.1] 770 (26.0) [24.4–27.6]
70 (4.2) [3.2–5.2] 283 (17.1) [15.3–18.9] 331 ± 1
72 (5.2) [4.0–6.4] 289 (21.0) [18.8–23.2]
142 (4.7) [3.9–5.5] 572 (18.9) [17.5–20.3]
] 58 (30.9) [24.3–37.5] 76 (40.4) [33.4–47.4] 120 ± 4
] 15 (24.6) [13.8–35.4] 25 (41.0) [28.7–53.3]
] 73 (29.3) [23.6–35.0] 101 (40.6) [34.5–46.7]
Table 4 Proportions of participants with headache reporting degrees of control of their headaches, by headache type and gender
Headache type Gender N In control of headaches
“Always” “Often” “Sometimes” “Rarely” “Never”
n (%) [95 % CI] n (%) [95 % CI] n (%) [95 % CI] n (%) [95 % CI] n (%) [95 % CI]
Migraine Female 2042 228 (11.2) [9.8–12.6] 812 (39.8) [37.7–41.9] 667 (32.7) [30.7–34.7] 214 (10.5) [9.2–11.8] 100 (4.9) [4.0–5.8]
Male 917 187 (20.4) [17.8–23.0] 344 (37.5) [34.4–40.6] 243 (26.5) [23.6–29.4] 80 (8.7) [6.9–10.5] 56 (6.1) [4.6–7.7]
All 2959 415 (14.0) [12.8–15.3] 1156 (39.1) [37.3–40.9] 910 (30.8) [29.1–32.5] 294 (9.9) [8.8–11.0] 157 (5.3) [4.5–6.1]
Tension–type
headache
Female 1657 566 (34.2) [31.9–36.5] 608 (36.7) [34.4–39.0] 307 (18.5) [16.6–20.4] 87 (5.3) [4.2–6.4] 54 (3.3) [2.4–4.2]
Male 1376 523 (38.0) [35.4–40.6] 470 (34.2) [31.7–36.7] 209 (15.2) [13.3–17.1] 79 (5.7) [4.5–6.9] 71 (5.2) [4.0–6.4]
All 3033 1089 (35.9) [34.2–37.6] 1078 (35.5) [33.8–37.2] 516 (17.0) [15.7–18.3] 166 (5.5) [4.7–6.3] 125 (4.1) [3.4–4.8]
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anxiety was reduced from 9.9 to 7.0 % (Fisher’s exact: p
= 0.0066), avoidance from 14.7 to 14.0 % (p = 0.6783); in
females with migraine, interictal anxiety was reduced
from 11.0 to 10.0 % (p = 0.3293), avoidance from 14.8 to
14.0 % (p = 0.5073). We did not undertake these analyses
in participants with TTH because their level of interictal
anxiety was so much lower, or in those with pMOH be-
cause of small numbers.
Stigma and social isolation
A third of respondents (32.9 %) with migraine and a
quarter (26.7 %) with TTH were reluctant to tell others
of their headaches (Table 6). This difference was significantTable 5 Probability of reporting interictal burden according to mea
Ictal burden measure
Headache intensity (reference: “not bad”) “bad”
“very bad”
Headache frequency (days/year) (reference: ≤12) 13–24
25–48
49–90
>90
In control of headaches (reference: “always”) “often”
“sometimes”
“rarely” or “never”
Lost productive time (HALT index): lost
work time (days/3 months) (reference: ≤11)
12–22
23–33
>33
lost household time (days/3 months) (reference: ≤11) 12–22
23–33
>33
lost work + household time + social
events (days/3 months) (reference: ≤22)
23–44
45–66
>66(chi-squared = 26.744; p < 0.0001). Gender differences were
minor. About 10 % with each disorder felt their families
and friends did not understand or accept their headaches.
Nearly 12 % with migraine who were employed reported
their employers and colleagues did not, but those with
TTH apparently fared better (6.6 %; chi-squared = 37.962;
p < 0.0001).
Cumulative burden
Finally we made enquiries among those with migraine
about cumulative burdens. We did not conduct this ana-
lysis among those with TTH, which is less recognisably a
lifelong condition. Overall, 11.8 % of participants with
migraine reported that they had done less well in theirsures of ictal burden in participants with migraine
Probability of reporting interictal burden
Odds ratio [95 % CI]
Interictal anxiety Interictal avoidance Not free of all symptoms
2.8 [1.5–5.4] 1.6 [1.1–2.4] 1.1 [0.8–1.4]
7.6 [4.0–14.7] 3.0 [2.0–4.6] 1.3 [1.0–1.8]
2.4 [1.5–3.7] 1.6 [1.1–2.2] 1.1 [0.8–1.4]
2.5 [1.7–3.8] 2.0 [1.5–2.8] 1.3 [1.0–1.6]
3.7 [2.5–5.6] 2.7 [1.9–3.6] 1.3 [1.0–1.6]
6.4 [4.3–9.6] 2.5 [1.8–3.6] 1.8 [1.3–2.3]
1.1 [0.7–1.9] 1.5 [1.0–2.2] 1.1 [1.1–1.9]
3.5 [2.1–5.6] 2.8 [1.9–4.1] 1.9 [1.4–2.5]
4.1 [2.5–6.9] 2.6 [1.7–3.9] 2.5 [1.8–3.4]
5.3 [3.6–7.9] 2.9 [1.9–4.3] 1.8 [1.2–2.6]
4.2 [2.0–8.9] 2.3 [1.1–5.0] 1.8 [0.9–3.7]
4.2 [1.7–10.2] 2.7 [1.1–6.6] 1.9 [0.8–4.4]
2.4 [1.7–3.6] 2.4 [1.7–3.4] 1.3 [0.9–1.8]
3.6 [2.1–6.3] 2.3 [1.3–4.0] 1.8 [1.1–3.0]
5.3 [2.6–10.7] 3.8 [1.9–7.6] 1.7 [0.9–3.5]
4.1 [2.9–5.7] 2.9 [2.1–4.0] 1.5 [1.1–2.0]
4.0 [2.2–7.2] 2.8 [1.6–5.0] 2.2 [1.3–3.6]
4.4 [2.3–8.3] 2.4 [1.3–4.5] 1.7 [1.0–3.1]
Table 6 Proportions of participants with headache responding adversely to questions on social isolation, by headache type and
gender
Headache type Gender N Avoid telling others Family, friends
don’t understand
N Employer, colleagues
don’t understand
n (%) [95 % CI] n (%) [95 % CI] n (%) [95 % CI]
Migraine Female 2042 691 (33.8) [31.8–35.9] 227 (11.1) [9.7–12.5] 1723 201 (11.7) [10.2–13.2]
Male 917 282 (30.8) [27.8–33.8] 76 (8.3) [6.5–10.1] 753 85 (11.3) [9.0–13.6]
All 2959 973 (32.9) [31.2–34.6] 303 (10.2) [9.1–11.3] 2476 292 (11.8) [10–5–13.1]
Tension–type headache Female 1657 429 (25.9) [23.8–28.0] 146 (8.8) [7.4–10.2] 1298 74 (5.7) [4.4–7.0]
Male 1376 382 (27.8) [25.4–30.2] 142 (10.3) [8.7–11.9] 1086 84 (7.7) [6.1–9.3]
All 3033 811 (26.7) [25.1–28.3] 288 (9.5) [8.5–10.5] 2384 158 (6.6) [5.6–7.6]
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was higher (14.1 %) in those aged <40 years. Reduced
earnings were reported by 5.9 %, while 7.4 % believed
their careers had suffered generally and they had done
less well than they might, but for their headaches. A
small proportion (2.1 %) had specifically taken easier
jobs, and 1.4 % had taken long-term sick leave.
Difficulties in love life were reported by 17.6 %, with
slightly more (18.8 %) among those under 40 years and a
marked gender difference (males 12.8 %, females
19.7 %). About 1 % of respondents reported having fewer
children, or had avoided having children altogether, be-
cause of their migraine. Very small proportions claimed
that migraine had caused marital separation (0.5 %) or
divorce (0.2 %).
Discussion
This was a large study of well over 6000 participants
drawn from nine countries of Europe. It suffered from
the limitations of the Eurolight study: it was not entirely
population-based, sampling methods differed between
countries (although to some extent this was a strength,
since it was not a purpose to compare countries [12]),
and participation rates were very low in some [19].
Nevertheless, this analysis leaves little doubt that interic-
tal burden exists as a significant consequence of episodic
headache. It is more evident in migraine than in TTH,
reflecting its strong relationship with ictal burden –
which is demonstrated here in several ways – but it is an
important finding that it is not restricted to migraine.
Avoidance, effectively meaning some degree of daily life-
style compromise, was reported by nearly 15 % (or one
in seven) with migraine compared to just under 5 %
(one in 21) with TTH. Worry about the next episode
was expressed by just over 10 % of those with migraine
and 3 % of those with TTH. These were differences by a
factor of about 3; however, while one quarter (26.0 %) of
participants with migraine reported that they were not
entirely free of symptoms interictally, the proportion
(18.9 %) with TTH who said the same was not so much
lower. Our enquiry did not extend into what the natureof these other interictal symptoms might be: this is fur-
ther work to be done.
Gender differences, incidentally, appeared to be minor.
The main exception to this was in proportions “always”
in control of their headaches, which favoured males with
either migraine or TTH. The determinants of feeling in
control are complex, and probably largely dependent on
effectiveness of acute therapy, whereas the perception of
not being in control is undoubtedly a contributor to
interictal burden. Of those with migraine, 15 % were
“rarely” or “never” in control, of those with TTH 10 %,
without significant gender differences.
Time spent in the interictal state, during which these
symptoms might continuously be present, was, on aver-
age, 317 days/year in those with migraine and 331 in
those with TTH. There is a conceptual issue in the esti-
mation of total interictal burden per year as the product:
[(burden assessed for a single day) x (days/year spent in
interictal state)]. This works for large groups, not for in-
dividuals. By enquiring into burden on the last day with-
out headache, we assumed this was a random day for
each participant. On any such random day, a representa-
tive proportion of participants would have experienced
interictal symptoms. It is not implied that interictal
symptoms are present throughout the time in the inter-
ictal state in every participant who reports such symp-
toms (although in some they may be), but rather that
the size of the proportion of people affected remains
more or less constant.
The randomness of this day might be questioned,
since by definition it was the last day of the interictal
period. Intuitively it might be expected that anxiety, at
least, builds over time during this period. In fact the evi-
dence is against this: the clear relationships between
interictal symptoms and headache frequency (Table 5)
indicate inverse relationships with length of interictal
period.
The last day without headache was also the day before
the last headache. There is a possibility, therefore, that
this enquiry captured premonitory symptoms, particu-
larly the non-specific third question (“On that day, did
Lampl et al. The Journal of Headache and Pain  (2016) 17:9 Page 8 of 10you feel completely free from all headache-related symp-
toms?”). This question had the highest proportion of ad-
verse responses (Table 3), but was least associated with
headache intensity or frequency (Table 5).
Time spent in the interictal state is, of course, in-
versely related to headache frequency. The relationship
between overall interictal burden and headache fre-
quency is likely to be complex; burden may be heavier
with higher frequency, but it is not borne for so long. In
migraine, there was a strong relationship between the
probability of interictal anxiety and headache frequency,
and a less strong relationship for avoidance.
Our enquiry into anxiety (or worry) was specifically di-
rected towards the next headache episode, and not
aimed at general anxiety (which is known to be comor-
bid with migraine and also related to attack frequency
[9, 20–22]). Perhaps not unexpectedly, we found a clear
association, in migraine, between interictal worry about
the next attack and general anxiety: those meeting
HADS caseness criteria for anxiety [18] were more than
twice as likely to report interictal anxiety as those in the
normal range. This association, which was graded, sug-
gests an aetiological relationship, but says nothing about
direction of causation. It should be noted that it was
much less strong than many associations between inter-
ictal anxiety and measures of ictal burden (Table 5). Fur-
thermore, when all participants meeting HADS caseness
criteria for anxiety (18.1 % of the total) were removed
from the analysis, proportions among the remainder
with interictal symptoms (including interictal anxiety)
were reduced but not greatly. In other words, general
anxiety cannot account for more than a very small part
of interictal anxiety.
The considerable reluctance to tell others of their
headaches (one third [32.9 %] with migraine and a quar-
ter [26.7 %] with TTH) may reflect natural reticence in
discussing health issues more than stigma attaching spe-
cifically to headache. The difference between disorders
was significant (p < 0.0001), whereas gender differences
were minor. On the other hand, employers and col-
leagues appeared to be rather understanding of respon-
dents’ headaches: 88–89 % in the case of migraine, and
about 93 % in the case of TTH (which probably caused
them less trouble). In fact, they were as accepting as
families and friends (about 90 % with each disorder).
Our enquiries into cumulative burden acknowledged
an additional dimension to interictal burden, potentially
very important in the context of a lifelong disorder [6, 7].
Doing less well in education because of headache was
reported by 11.8 % of participants with migraine. Ad-
mittedly this might be a subjective judgment based on
recall, perhaps from long ago, but 11.8 % is a large and
noteworthy proportion. We could not measure the con-
sequences of disrupted education, but they could behuge over a lifetime, and this finding is a reminder, if it
is needed, of the importance of headache in childhood
and adolescence. Some of the consequences were, per-
haps, evident in responses to subsequent questions: re-
duced earnings, reported by 5.9 %; careers suffering,
reported by 7.4 %. Then there were those who had ef-
fectively given up: 2.1 % who had taken an easier job,
and 1.4 % on long-term sick leave – small numbers, but
these outcomes represented profound consequences for
these people and their dependents.
Difficulties in love life were common (17.6 %), and
here there was a marked gender difference (male-to-
female ratio 2:3). The 1 % who had had fewer children
because of their migraine reflected another profound
life-affecting consequence.
There are few previous studies with which to make
comparisons. Boardman et al. argued that migraine pain
would lead to isolation from social, emotional and be-
havioural aspects of life, and could greatly impact on
these between attacks, being in this regard similar to
other painful syndromes [23]. A Swedish study among
patients in a migraine clinic revealed less contentment
and vitality and poorer sleep and sense of wellbeing,
coupled with more subjective symptoms in the
headache-free periods, than among a population-based
control group [24]. A population-based study in the
same country found that only 43 % of people with mi-
graine recovered completely between attacks [11]. This
implied a far higher proportion (57 %) not free of all
symptoms interictally than we found (26 %), but there
was no description of what type of symptoms persisted,
and some participants might have had more or less
chronic headache. In a UK study, at least two thirds
(66 %) of 158 hospital employees with migraine reported
some form of impact between attacks, including interfer-
ence with family (54 %) or work (35 %) relationships,
feelings of not being in control of their lives (34 %) and
damaged chances of promotion (15 %) [25]. “Not in con-
trol of lives” cannot be compared with our enquiry “not
in control of headaches”, but generally these findings in-
dicate greater interictal impact than ours. However, par-
ticipation rate in the survey was 45 %, there was gender
bias (93 % of the 158 were female) and, taking the nature
of the population also into account, interest bias was
highly likely. In these and other reports [6–9], the exist-
ence of interictal burden has clearly been recognised; in
the latter, furthermore, many of its elements have been
well described [6–9]. This study, however, is the first to
estimate their general population prevalence.
A limitation was that our questions mostly invited yes/no
responses. Therefore we could capture prevalence but
not magnitude. The methodology for magnitude estima-
tion has yet to be developed: it does not exist in recom-
mendations for burden estimation so far put forward [7].
Lampl et al. The Journal of Headache and Pain  (2016) 17:9 Page 9 of 10What this study has shown is that the methodology is
needed: the high prevalence of interictal burden demands
it if the burden of headache is to be adequately described.Conclusions
Interictal burden in those with episodic headache is
common, more so in migraine than in TTH, but, im-
portantly, it is not restricted to those with migraine. It
shows a relationship with ictal burden. Although we did
not assess the magnitude of burden, some elements – in
particular those that are cumulative – have the potential
to be profoundly consequential. There is a need for new
methodology to measure interictal burden if descriptions
of headache burden are to be complete.
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